Validity of animal models of type 1 diabetes, and strategies to enhance their utility in translational research

European Journal of Pharmacology

Volumn 759, Issue , 2015, Pages 221-230

  Graham, Melanie L ^a   Schuurman, Henk Jan ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b SchuBiomed Consultancy   (Netherlands)

Author keywords

Animal models; Cell therapy; Immunosuppressives; Nonhuman primate; Rodent; Type 1 diabetes

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ANIMAL; CELL TRANSPLANTATION; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; HUMAN; IMMUNOLOGY; PANCREAS ISLET BETA CELL; PROCEDURES; SPECIES DIFFERENCE; TRANSLATIONAL RESEARCH; TRANSPLANTATION;

ANIMALS; CELL TRANSPLANTATION; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INSULIN-SECRETING CELLS; SPECIES SPECIFICITY; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84937761242     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2015.02.054     Document Type: Review

References (141)

1. A.B. Adams, N. Shirasugi, M.M. Durham, E. Strobert, D. Anderson, P. Rees, S. Cowan, H. Xu, Y. Blinder, M. Cheung, D. Hollenbaugh, N.S. Kenyon, T.C. Pearson, and C.P. Larsen Calcineurin inhibitor-free CD28 blockade-based protocol protects allogeneic islets in nonhuman primates Diabetes 51 2002 265 270
2. T. Agathocles The role of T regulatory cells (Tregs) in the development and prevention of type 1 diabetes J. Clin. Cell. Immunol. S2 2012 003
3. L. Åkerman, J. Ludvigsson, and R. Casas Low C-peptide levels and decreased expression of TNF and CD45 in children with high risk of type 1 diabetes Clin. Immunol. 148 2013 4 15
4. R. Alejandro, F.B. Barton, B.J. Hering, and S. Wease 2008 Update from the Collaborative Islet Transplant Registry Collaborative Islet Transplant Registry Investigators Transplantation 86 2008 1783 1788
5. M.S. Anderson, and J.A. Bluestone The NOD mouse: a model of immune dysregulation Annu. Rev. Immunol. 23 2005 447 485
6. E. Araki, S. Oyadomari, and M. Mori Impact of endoplasmic reticulum stress pathway on pancreatic beta-cells and diabetes mellitus Exp. Biol. Med. (Maywood) 228 2003 1213 1217
7. W.F. Ballinger, P.E. Lacy, R.F. Gittes, J.E. Altwein, S.S. Yen, S. Lee, H.C. Miller, J.W. Alexander, and P. Nathan Transplantation of intact pancreatic islets in rats Carbon 220 1972 228
8. A. Banga, E. Akinci, L.V. Greder, J.R. Dutton, and J.M. Slack In vivo reprogramming of Sox9+ cells in the liver to insulin-secreting ducts Proc. Natl. Acad. Sci. U.S.A. 109 2012 15336 15341
9. M. Bao, Y. Yang, H.S. Jun, and J.W. Yoon Molecular mechanisms for gender differences in susceptibility to T cell-mediated autoimmune diabetes in nonobese diabetic mice J. Immunol. 168 2002 5369 5375
10. F.B. Barton, M.R. Rickels, R. Alejandro, B.J. Hering, S. Wease, B. Naziruddin, J. Oberholzer, J.S. Odorico, M.R. Garfinkel, M. Levy, F. Pattou, T. Berney, A. Secchi, S. Messinger, P.A. Senior, P. Maffi, A. Posselt, P.G. Stock, D.B. Kaufman, X. Luo, F. Kandeel, E. Cagliero, N.A. Turgeon, P. Witkowski, A. Naji, P.J. O'Connell, C. Greenbaum, Y.C. Kudva, K.L. Brayman, M.J. Aull, C. Larsen, T.W. Kay, L.A. Fernandez, M.C. Vantyghem, M. Bellin, and A.M. Shapiro Improvement in outcomes of clinical islet transplantation: 1999-2010 Diabetes Care 35 2012 1436 1445
11. R. Bassi, and P. Fiorina Impact of islet transplantation on diabetes complications and quality of life Curr. Diab. Rep. 11 2011 355 363
12. J. Beckwith, J.A. Nyman, B. Flanagan, R. Schrover, and H.-J. Schuurman A health economic analysis of clinical islet transplantation Clin. Transplant. 26 2012 23 33
13. T. Berney, L. Buhler, P. Majno, G. Mentha, and P. Morel Immunosuppression for pancreatic islet transplantation Transplant. Proc. 36 2004 S362 S366
14. M. Bliss Discovery of Insulin 2000 University of Chicago Press
15. M. Boroujerdi, A. Umpleby, R. Jones, and P. Sonksen A simulation model for glucose kinetics and estimates of glucose utilization rate in type 1 diabetic patients Am. J. Physiol. 31 1995 E766 E774
16. M.A. Brehm, L.D. Shultz, and D.L. Greiner Humanized mouse models to study human diseases Curr. Opin. Endocrinol. Diabetes Obes. 17 2010 120 125
17. K. Cardona, G.S. Korbutt, Z. Milas, J. Lyon, J. Cano, W. Jiang, H. Bello-Laborn, B. Hacquoil, E. Strobert, and S. Gangappa Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways Nat. Med. 12 2006 304 306
18. S.L. Carney, N.L. Wong, and J.H. Dirks Acute effects of streptozotocin diabetes on rat renal function J. Lab. Clin. Med. 93 1979 950 961
19. A. Casu, R. Bottino, A.N. Balamurugan, H. Hara, D.J. van der Windt, N. Campanile, C. Smetanka, D.K.C. Cooper, and M. Trucco Metabolic aspects of pig-to-monkey (Macaca fascicularis) islet transplantation: implications for translation into clinical practice Diabetologia 51 2008 120 129
20. B. Chandrasekar, and S. Mukherjee Effect of prolonged administration of cyclosporin A on (pro) insulin biosynthesis and insulin release by rat islets of Langerhans Biochem. Pharmacol. 37 1988 3609 3611
21. J. Chang, and S.B. Gurley Assessment of diabetic nephropathy in the Akita mouse H.G. Joost, H. Al-Hasani, A. Schürmann, Animal Models in Diabetes Research. Methods in Molecular Biology vol. 933 2012 Springer Science+Business Media 17 29
22. K. Chapman, N. Pullen, M. Graham, and I. Ragan Preclinical safety testing of monoclonal antibodies: the significance of species relevance Nat. Rev. Drug Discovery 6 2007 120 126
23. C. Chappel, and W. Chappel The discovery and development of the BB rat colony: an animal model of spontaneous diabetes mellitus Metab. Clin. Exp. 32 1983 8 10
24. R. Chen, M. Meseck, R.C. McEvoy, and S.L. Woo Glucose-stimulated and self-limiting insulin production by glucose 6-phosphatase promoter driven insulin expression in hepatoma cells Gene Ther. 7 2000 1802 1809
25. D. Cheţa Animal models of type I (insulin-dependent) diabetes mellitus J. Pediatr. Endocrinol. Metab. 11 1998 11 19
26. R.J. Christopher, K. Takeuchi, and B. Lee Rodent models of diabetes L. Poretsky, Principles of Diabetes Mellitus 2010 Springer Science+Business Media 165 178
27. D.K.C. Cooper, and A. Casu The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes - Chapter 4: pre-clinical efficacy and complication data required to justify a clinical trial Xenotransplantation 16 2009 229 238
28. P. Cure, A. Pileggi, T. Froud, S. Messinger, R.N. Faradji, D.A. Baidal, R. Cardani, A. Curry, R. Poggioli, and A. Pugliese Improved metabolic control and quality of life in seven patients with type 1 diabetes following islet after kidney transplantation Transplantation 85 2008 801 812
29. DCCT The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus The Diabetes Control and Complications Trial Research Group N. Engl. J. Med. 329 1993 977 986
30. DAIT, NIAID, NIH, 2008. Purified Human Pancreatic Islets, In Vivo Islets Function. Assay Instructions, Document no. 3104, A04, Effective Date 07 July 2008. . Accessed December 26, 2014.
31. M. Davies, J. Gagliardino, L. Gray, K. Khunti, V. Mohan, and R. Hughes Real-world factors affecting adherence to insulin therapy in patients with Type 1 or Type 2 diabetes mellitus: a systematic review Diabet. Med. 30 2013 512 524
32. M.C. Deeds, J.M. Anderson, A.S. Armstrong, D.A. Gastineau, H.J. Hiddinga, A. Jahangir, N.L. Eberhardt, and Y.C. Kudva Single dose streptozotocin-induced diabetes: considerations for study design in islet transplantation models Lab. Anim. 45 2011 131 140
33. T. Denayer, T. Stöhr, and M. Van Roy Animal models in translational medicine: validation and prediction New Horiz. Transl. Med. 2 2014 5 11
34. J.P. Driver, D.V. Serreze, and Y. Chen Mouse models for the study of autoimmune type 1 diabetes: a NOD to similarities and differences to human disease Semin. Immunopathol. 33 2011 67 87
35. D. Dufrane, R.M. Goebbels, A. Saliez, Y. Guiot, and P. Gianello Six-month survival of microencapsulated pig islets and alginate biocompatibility in primates: proof of concept Transplantation 81 2006 1345 1353
36. C.O. Eleazu, K.C. Eleazu, S. Chukwuma, and U.N. Essien Review of the mechanism of cell death resulting from streptozotocin challenge in experimental animals, its practical use and potential risk to humans J. Diabetes Metab. Disord. 23 60 2013 6581-12-60
37. B.G. Elferink, A. Geluk, N. Otting, B.L. Slierendregt, K.E. van Meijgaarden, R.R. de Vries, T.H. Ottenhoff, and R.E. Bontrop The biologic importance of conserved major histocompatibility complex class II motifs in primates Hum. Immunol. 38 1993 201 205
38. M. Figliuzzi, R. Bianchi, C. Cavagnini, R. Lombardi, C. Porretta-Serapiglia, G. Lauria, F. Avezza, A. Canta, V. Carozzi, and A. Chiorazzi Islet transplantation and insulin administration relieve long-term complications and rescue the residual endogenous pancreatic β cells Am. J. Pathol. 183 2013 1527 1538
39. J. Fricker The pig: a new model of diabetic atherosclerosis Drug Discovery Today 6 2001 921 922
40. U. Galili The α-gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy Immunol. Cell Biol. 83 2005 674 686
41. O. Garkavenko, B. Dieckhoff, S. Wynyard, J. Denner, R.B. Elliott, P.L. Tan, and M.C. Croxson Absence of transmission of potentially xenotic viruses in a prospective pig to primate islet xenotransplantation study J. Med. Virol. 80 2008 2046 2052
42. L.K. Gaur Nonhuman primate models for islet transplantation in type 1 diabetes research ILAR J. 45 2004 324 333
43. A. Geluk, D.G. Elferink, B.L. Slierendregt, K.E. van Meijgaarden, R.R. de Vries, T.H. Ottenhoff, and R.E. Bontrop Evolutionary conservation of major histocompatibility complex-DR/peptide/T cell interactions in primates J. Exp. Med. 177 1993 979 987
44. R.G. Gerrity, R. Natarajan, J.L. Nadler, and T. Kimsey Diabetes-induced accelerated atherosclerosis in swine Diabetes 50 2001 1654 1665
45. M.L. Graham, and H.-J. Schuurman The usefulness and limitations of the diabetic macaque model in evaluating long-term porcine islet xenograft survival Xenotransplantation 20 2013 5 17
46. M.L. Graham, E.F. Rieke, M. Dunning, L.A. Mutch, A.M. Craig, E.K. Zolondek, B.J. Hering, H.-J. Schuurman, and R.W. Bianco A novel alternative placement site and technique for totally implantable vascular access ports in non-human primates J. Med. Primatol. 38 2009 204 212
47. M.L. Graham, L.A. Mutch, E.F. Rieke, M. Dunning, E.K. Zolondek, A.W. Faig, B.J. Hering, and H.-J. Schuurman Refinement of vascular access port placement in nonhuman primates: complication rates and outcomes Comp. Med. 60 2010 479 485
48. M.L. Graham, M.D. Bellin, K.K. Papas, B.J. Hering, and H.-J. Schuurman Species incompatibilities in the pig-to-macaque islet xenotransplant model affect transplant outcome: a comparison with allotransplantation Xenotransplantation 18 2011 328 342
49. M.L. Graham, J.L. Janecek, J.A. Kittredge, B.J. Hering, and H.-J. Schuurman The streptozotocin-induced diabetic nude mouse model: differences between animals from different sources Comp. Med. 61 2011 356 360
50. M.L. Graham, L.A. Mutch, E.F. Rieke, J.A. Kittredge, A.W. Faig, T.A. DuFour, J.W. Munson, E.K. Zolondek, B.J. Hering, and H.-J. Schuurman Refining the high-dose streptozotocin-induced diabetic non-human primate model: an evaluation of risk factors and outcomes Exp. Biol. Med. 236 2011 1218 1230
51. M.L. Graham, L.A. Mutch, J.A. Kittredge, E.F. Rieke, N.A. Robinson, E.K. Zolondek, A.W. Faig, T.A. DuFour, J.W. Munson, and H.-J. Schuurman Management of adverse side-effects after chemotherapy in macaques as exemplified by streptozotocin: case studies and recommendations Lab. Anim. 46 2012 178 192
52. M.L. Graham, E.F. Rieke, L.A. Mutch, E.K. Zolondek, A.W. Faig, T.A. DuFour, J.W. Munson, J.A. Kittredge, and H.-J. Schuurman Successful implementation of cooperative handling eliminates the need for restraint in a complex non-human primate disease model J. Med. Primatol. 41 2012 89 106
53. C.W. Grant, S.K. Duclos, C.M. Moran-Paul, B. Yahalom, R.S. Tirabassi, G. Arreaza-Rubin, L.M. Spain, and D.L. Guberski Development of standardized insulin treatment protocols for spontaneous rodent models of type 1 diabetes Comp. Med 62 2012 381 390
54. D.L. Greiner, E.S. Handler, K. Nakano, J.P. Mordes, and A.A. Rossini Absence of the RT-6T cell subset in diabetes-prone BB/W rats J. Immunol. 136 1986 148 151
55. D.L. Greiner, A.A. Rossini, and J.P. Mordes Translating data from animal models into methods for preventing human autoimmune diabetes mellitus: caveat emptor and primum non nocere Clin. Immunol. 100 2001 134 143
56. R. Grüßner, A. Nakhleh, G. Grüßner, P. Tomadze, D. Diem, and D.E. Sutherland Streptozotocin-induced diabetes mellitus in pigs Horm. Metab. Res. 25 1993 199 203
57. D.L. Guberski, V.A. Thomas, W.R. Shek, A.A. Like, E.S. Handler, A.A. Rossini, J.E. Wallace, and R.M. Welsh Induction of type 1 diabetes by Kilham's rat virus in diabetes-resistant BB/Wor rats Science 254 1991 1010 1013
58. K.G. Haanstra, and M. Jonker Non-human primate models in allo-transplantation research: a short review Drug Discovery Today Dis. Models 5 2008 73 79
59. P.A. Halban, S.E. Kahn, A. Lernmark, and C.J. Rhodes Gene and cell-replacement therapy in the treatment of type 1 diabetes: how high must the standards be set? Diabetes 50 2001 2181 2191
60. B.J. Hering, M. Wijkstrom, M.L. Graham, M. Hårdstedt, T.C. Aasheim, T. Jie, J.D. Ansite, M. Nakano, J. Cheng, W. Li, K. Moran, U. Christians, C. Finnegan, C.D. Mills, D.E. Sutherland, P. Bansal-Pakala, M.P. Murtaugh, N. Kirchhof, and H.-J. Schuurman Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates Nat. Med. 12 2006 301 303
61. C.F. Howard Jr Nonhuman primates as models for the study of human diabetes mellitus Diabetes 31 1982 37 42
62. K. Inoue, M. Cetkovic-Cvrlje, D.L. Eizirik, and V. Grill Irreversible loss of normal beta-cell regulation by glucose in neonatally streptozotocin diabetic rats Diabetologia 37 1994 351 357
63. International Diabetes Federation2013. IDF DIABETES ATLAS, Sixth edition Online version: . Accessed December 26, 2014.
64. A.M. Jacobson, B.H. Braffett, P.A. Cleary, R.A. Gubitosi-Klug, and M.E. Larkin The long-term effects of type 1 diabetes treatment and complications on health-related quality of life: a 23-year follow-up of the Diabetes Control and Complications/Epidemiology of Diabetes Interventions and Complications cohort Diabetes Care 36 2013 3131 3138
65. H. Jun, and J. Yoon The role of viruses in type 1 diabetes: two distinct cellular and molecular pathogenic mechanisms of virus-induced diabetes in animals Diabetologia 44 2001 271 285
66. A. Junod, A.E. Lambert, W. Stauffacher, and A.E. Renold Diabetogenic action of streptozotocin: relationship of dose to metabolic response J. Clin. Invest. 48 1969 2129 2139
67. G. Kantwerk-Funke, V. Burkart, and H. Kolb Low dose streptozotocin causes stimulation of the immune system and of anti-islet cytotoxicity in mice Clin. Exp. Immunol. 86 1991 266 270
68. U. Kiesel, and H. Kolb Low-dose streptozotocin-induced autoimmune diabetes is under the genetic control of the major histocompatibility complex in mice Diabetologia 23 1982 69 71
69. A.J. King The use of animal models in diabetes research Br. J. Pharmacol. 166 2012 877 894
70. A.D. Kirk Transplantation tolerance: a look at the nonhuman primate literature in the light of modern tolerance theories Crit. Rev. Immunol. 19 1999 349 388
71. S.J. Koopmans, Z. Mroz, R. Dekker, H. Corbijn, M. Ackermans, and H. Sauerwein Association of insulin resistance with hyperglycemia in streptozotocin-diabetic pigs: effects of metformin at isoenergetic feeding in a type 2-like diabetic pig model Metab. Clin. Exp. 55 2006 960 971
72. S.J. Koopmans, J. VanderMeulen, J. Wijdenes, H. Corbijn, and R. Dekker The existence of an insulin-stimulated glucose and non-essential but not essential amino acid substrate interaction in diabetic pigs BMC Biochem. 12 2011 25 2091-12-25
73. M. Koulmanda, A. Qipo, S. Chebrolu, J. O'Neil, H. Auchincloss, and R.N. Smith The effect of low versus high dose of streptozotocin in cynomolgus monkeys (Macaca fascilularis) Am. J. Transplant. 3 2003 267 272
74. B.P. Kovatchev, M. Breton, C.D. Man, and C. Cobelli In silico preclinical trials: a proof of concept in closed-loop control of type 1 diabetes J. Diabetes Sci. Technol. 3 2009 44 55
75. K.O. Kyvik, A. Green, and H. Beck-Nielsen Concordance rates of insulin dependent diabetes mellitus: a population based study of young Danish twins BMJ 311 1995 913 917
76. E. Lampeter, A. Signore, E. Gale, and P. Pozzilli Lessons from the NOD mouse for the pathogenesis and immunotherapy of human type 1 (insulin-dependent) diabetes mellitus Diabetologia 32 1989 703 708
77. B. Lapin, T. Gvozdik, and I. Klots Blood glucose levels in rhesus monkeys (Macaca mulatta) and cynomolgus macaques (Macaca fascicularis) under moderate stress and after recovery Bull. Exp. Biol. Med. 154 2013 497 500
78. C.P. Larsen, T.C. Pearson, A.B. Adams, P. Tso, N. Shirasugi, E. Strobertm, D. Anderson, S. Cowan, K. Price, J. Naemura, J. Emswiler, J. Greene, L.A. Turk, J. Bajorath, R. Townsend, D. Hagerty, P.S. Linsley, and R.J. Peach Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties Am. J. Transplant. 5 2005 443 453
79. M.O. Larsen, and B. Rolin Use of the Göttingen minipig as a model of diabetes, with special focus on type 1 diabetes research ILAR J. 45 2004 303 313
80. H.C. Lee, S. Kim, K. Kim, H. Shin, and J. Yoon Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogue Nature 408 2000 483 488
81. J. Lee, J. Shin, W. Jung, G. Lee, M. Kim, Y. Kim, J. Choi, C. Park, and S. Kim Porcine islet adaptation to metabolic need of monkeys in pig-to-monkey intraportal islet xenotransplantation Transplant. Proc. 45 2013 1866 1868
82. J. Lee, T. Sugiyama, Y. Liu, J. Wang, X. Gu, J. Lei, J.F. Markmann, S. Miyazaki, J. Miyazaki, G.L. Szot, R. Bottino, and S.K. Kim Expansion and conversion of human pancreatic ductal cells into insulin-secreting endocrine cells Elife 2 2013 e00940
83. E.H. Leiter Multiple low-dose streptozotocin-induced hyperglycemia and insulitis in C57BL mice: influence of inbred background, sex, and thymus Proc. Natl. Acad. Sci. U.S.A. 79 1982 630 634
84. E.H. Leiter, M. Prochazka, and D.L. Coleman The non-obese diabetic (NOD) mouse Am. J. Pathol. 128 1987 380 383
85. S. Lenzen The mechanisms of alloxan- and streptozotocin-induced diabetes Diabetologia 51 2008 216 226
86. ® islet model for diabetic drug efficacy testing PLoS One 8 2013 e72612
87. A.A. Like, L. Butler, R.M. Williams, M.C. Appel, E.J. Weringer, and A.A. Rossini Spontaneous autoimmune diabetes mellitus in the BB rat Diabetes 31 1982 7 13
88. D.M. Maahs, N.A. West, J.M. Lawrence, and E.J. Mayer-Davis Epidemiology of type 1 diabetes Endocrinol. Metab. Clin. North Am. 39 2010 481 497
89. A.J. MacMurray, D.H. Moralejo, A.E. Kwitek, E.A. Rutledge, B. Van Yserloo, P. Gohlke, S.J. Speros, B. Snyder, J. Schaefer, S. Bieg, J. Jiang, R.A. Ettinger, J. Fuller, T.L. Daniels, A. Pettersson, K. Orlebeke, B. Birren, H.J. Jacob, E.S. Lander, and A. Lernmark Lymphopenia in the BB rat model of type 1 diabetes is due to a mutation in a novel immune-associated nucleotide (Ian)-related gene Genome Res. 12 2002 1029 1039
90. L. Magni, D.M. Raimondo, L. Bossi, C. Dalla Man, G. De Nicolao, B. Kovatchev, and C. Cobelli Model predictive control of type 1 diabetes: an in silico trial J. Diabetes Sci. Technol. 1 2007 804 812
91. P. McGonigle, and B. Ruggeri Animal models of human disease: challenges in enabling translation Biochem. Pharmacol. 87 2014 162 171
92. J. Mestas, and C.C. Hughes Of mice and not men: differences between mouse and human immunology J. Immunol. 172 2004 2731 2738
93. C.J. Murray, and A.D. Lopez Measuring the global burden of disease N. Engl. J. Med. 369 2013 448 457
94. G.R. Nemerow Cell receptors involved in adenovirus entry Virology 274 2000 1 4
95. P.J. O'Connell The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes - Chapter 6: patient selection for pilot clinical trials of islet xenotransplantation Xenotransplantation 16 2009 249 254
96. F.W. Pagliuca, J.R. Millman, M. Gürtler, M. Segel, A. Van Dervort, J.H. Ryu, Q.P. Peterson, D. Greiner, and D.A. Melton Generation of functional human pancreatic β cells in vitro Cell 159 2014 428 439
97. F. Palm, H. Ortsäter, P. Hansell, P. Liss, and P.O. Carlsson Differentiating between effects of streptozotocin per se and subsequent hyperglycemia on renal function and metabolism in the streptozotocin-diabetic rat model Diabetes Metab. Res. Rev. 20 2004 452 459
98. A.R. Pepper, C. Gall, D.M. Mazzuca, C.W.J. Melling, and D.J. White Diabetic rats and mice are resistant to porcine and human insulin: flawed experimental models for testing islet xenografts Xenotransplantation 16 2009 502 510
99. A.M. Posselt, G.L. Szot, L.A. Frassetto, U. Masharani, M. Tavakol, R. Amin, J. McElroy, M.D. Ramos, R.K. Kerlan, L. Fong, F. Vincenti, J.A. Bluestone, and P.G. Stock Islet transplantation in type 1 diabetic patients using calcineurin inhibitor-free immunosuppressive protocols based on T-cell adhesion or costimulation blockade Transplantation 90 2010 1595 1601
100. P. Pozzilli, A. Signore, A.J. Williams, and P.E. Beales NOD mouse colonies around the world-recent facts and figures Immunol. Today 14 1993 193 196
101. A. Rezania, J.E. Bruin, P. Arora, A. Rubin, I. Batushansky, A. Asadi, S. O'Dwyer, N. Quiskamp, M. Mojibian, and T. Albrecht Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells Nat. Biotechnol. 32 2014 1121 1133
102. C. Ricordi, Y.J. Zeng, R. Alejandro, A. Tzakis, R. Venkataramanan, J. Fung, D. Bereiter, D.H. Mintz, and T.E. Starzl In vivo effect of FK506 on human pancreatic islets Transplantation 52 1991 519 522
103. C. Ricordi, Y. Zeng, R. Alejandro, A. Tzakis, P. Carroll, H.L.R. Rilo, R. Venkataramanan, J.J. Fung, D. Bereiter, and T.E. Starzl Effect of FK 506 on human pancreatic islets following renal subcapsular transplantation in diabetic nude mice Transplant. Proc. 24 1992 1042
104. C. Ricordi, A.G. Tzakis, P.B. Carroll, Y.J. Zeng, H.L. Rilo, R. Alejandro, A. Shapiro, J.J. Fung, A.J. Demetris, and D.H. Mintz Human islet isolation and allotransplantation in 22 consecutive cases Transplantation 53 1992 407 414
105. B.O. Roep, M. Atkinson, and M. von Herrath Satisfaction (not) guaranteed: re-evaluating the use of animal models of type 1 diabetes Nat. Rev. Immunol. 4 2004 989 997
106. P.P. Rood, R. Bottino, A.N. Balamurugan, C. Smetanka, M. Ezzelarab, J. Busch, H. Hara, M. Trucco, and D.K. Cooper Induction of diabetes in cynomolgus monkeys with high-dose streptozotocin: adverse effects and early responses Pancreas 33 2006 287 292
107. J.G. Rosmalen, T. Martin, C. Dobbs, J.S. Voerman, H.A. Drexhage, K. Haskins, and P.J. Leenen Subsets of macrophages and dendritic cells in nonobese diabetic mouse pancreatic inflammatory infiltrates: correlation with the development of diabetes Lab. Invest. 80 2000 23 30
108. A.A. Rossini, A.A. Like, W.L. Chick, M.C. Appel, and G.F. Cahill Jr Studies of streptozotocin-induced insulitis and diabetes Proc. Natl. Acad. Sci. U.S.A. 74 1977 2485 2489
109. A. Rydén, and M. Faresjö Altered immune profile from pre-diabetes to manifestation of type 1 diabetes Diabetes Res. Clin. Pract. 100 2013 74 84
110. F. Sams-Dodd Strategies to optimize the validity of disease models in the drug discovery process Drug Discovery Today 11 2006 355 363
111. D.W. Scharp, J.J. Murphy, W.T. Newton, W.F. Ballinger, and P.E. Lacy Transplantation of islets of Langerhans in diabetic rhesus monkeys Surgery 77 1975 100 105
112. D.W. Scharp, P.E. Lacy, J.V. Santiago, C.S. McCullough, L.G. Weide, L. Falqui, P. Marchetti, R.L. Gingerich, A.S. Jaffe, and P.E. Cryer Insulin independence after islet transplantation into type I diabetic patient Diabetes 39 1990 515 518
113. H.-J. Schuurman Xenotransplantation Drug Discovery Today Dis. Models 5 2008 81 87
114. S. Shibata, N. Kirchhof, S. Matsumoto, J. Sageshima, K. Hiraoka, J. Ansite, M. Wistrom, D.E. Sutherland, and B.J. Hering High-dose streptozotocin for diabetes induction in adult rhesus monkeys Transplant. Proc. 34 2002 1341 1344
115. Y. Shirasaki, N. Yoshioka, K. Kanazawa, T. Maekawa, T. Horikawa, and T. Hayashi Effect of physical restraint on glucose tolerance in cynomolgus monkeys J. Med. Primatol. 42 2013 65 68
116. L.K. Shoda, D.L. Young, S. Ramanujan, C.C. Whiting, M.A. Atkinson, J.A. Bluestone, G.S. Eisenbarth, D. Mathis, A.A. Rossini, and S.E. Campbell A comprehensive review of interventions in the NOD mouse and implications for translation Immunity 23 2005 115 126
117. M.J. Smith, T.A. Packard, S.K. O'Neill, C.J. Henry Dunand, M. Huang, L. Fitzgerald-Miller, D. Stowell, R.M. Hinman, P.C. Wilson, P.A. Gottlieb, and J.C. Cambier Loss of anergic B Cells in pre-diabetic and new onset T1D patients Diabetes 2014 [Epub ahead of print]
118. J. Stephenson Studies illuminate cause of fatal reaction in gene-therapy trial JAMA 285 2001 2570-2570
119. T.C. Thayer, S.B. Wilson, and C.E. Mathews Use of nonobese diabetic mice to understand human type 1 diabetes Endocrinol. Metab. Clin. North Am. 39 2010 541 561
120. D.M. Thompson, M. Meloche, Z. Ao, B. Paty, P. Keown, R.J. Shapiro, S. Ho, D. Worsley, M. Fung, and G. Meneilly Reduced progression of diabetic microvascular complications with islet cell transplantation compared with intensive medical therapy Transplantation 91 2011 373 378
121. G. Thomson, W.P. Robinson, M.K. Kuhner, S. Joe, M.J. MacDonald, J.L. Gottschall, J. Barbosa, S.S. Rich, J. Bertrams, and M.P. Baur Genetic heterogeneity, modes of inheritance, and risk estimates for a joint study of Caucasians with insulin-dependent diabetes mellitus Am. J. Hum. Genet. 43 1988 799 816
122. R. Tisch, and H. McDevitt Insulin-dependent diabetes mellitus Cell 85 1996 291 297
123. Type 1 Diabetes Study Group, Diabetes Prevention Trial Effects of insulin in relatives of patients with type 1 diabetes mellitus N. Engl. J. Med. 346 2002 1685 1691
124. M. Vaccari, and G. Franchini Memory T cells in rhesus macaques Adv. Exp. Med. Biol. 684 2010 126 144
125. T.L. Van Belle, P. Taylor, and M.G. Von Herrath Mouse models for type 1 diabetes Drug Discovery Today Dis. Models 6 2009 41 45
126. D. Van der Windt, R. Bottino, A. Casu, N. Campanile, C. Smetanka, J. He, N. Murase, H. Hara, S. Ball, and B. Loveland Long-term controlled normoglycemia in diabetic non-human primates after transplantation with hCD46 transgenic porcine islets Am. J. Transplant. 9 2009 2716 2726
127. K. Vehik, N.J. Ajami, D. Hadley, J.F. Petrosino, and B.R. Burkhardt The changing landscape of type 1 diabetes: recent developments and future frontiers Curr. Diab. Rep. 13 2013 642 650
128. A.M. Vincent, M.J. Stevens, C. Backus, L.L. Mclean, and E.L. Feldman Cell culture modeling to test therapies against hyperglycemia-mediated oxidative stress and injury Antioxid. Redox Signal. 7 2005 1494 1506
129. F. Vincenti, C. Larsen, A. Durrbach, T. Wekerle, B. Nashan, G. Blancho, P. Lang, J. Grinyo, P.F. Halloran, K. Solez, D. Hagerty, E. Levy, W. Zhou, K. Natarajan, and B. Charpentier Costimulation blockade with belatacept in renal transplantation N. Engl. J. Med. 353 2005 770 781
130. M. Von Herrath, and G.T. Nepom Animal models of human type 1 diabetes Nat. Immunol. 10 2009 129 132
131. P. Wang, J. Lau, and T. Chalmers Meta-analysis of effects of intensive blood-glucose control on late complications of type I diabetes Lancet 341 1993 1306 1309
132. G.L. Warnock, D.M. Thompson, R.M. Meloche, R.J. Shapiro, Z. Ao, P. Keown, J.D. Johnson, C.B. Verchere, N. Partovi, and I.S. Begg A multi-year analysis of islet transplantation compared with intensive medical therapy on progression of complications in type 1 diabetes Transplantation 86 2008 1762 1766
133. L. Wei, Y. Lu, S. He, X. Jin, L. Zeng, S. Zhang, Y. Chen, B. Tian, G. Mai, and G. Yang Induction of diabetes with signs of autoimmunity in primates by the injection of multiple-low-dose streptozotocin Biochem. Biophys. Res. Commun. 412 2011 373 378
134. M. Wijkstrom, N. Kirchhof, M. Graham, E. Ingulli, R.B. Colvin, U. Christians, B.J. Hering, and H. Schuurman Cyclosporine toxicity in immunosuppressed streptozotocin-diabetic nonhuman primates Toxicology 207 2005 117 127
135. M. Wijkstrom, R. Bottino, and D.K. Cooper Limitations of the pig-to-non-human primate islet transplantation model Xenotransplantation 20 2013 2 4
136. F.S. Wong, and C.A. Janeway Jr Insulin-dependent diabetes mellitus and its animal models Curr. Opin. Immunol. 11 1999 643 647
137. D. Wu, C. Zou, F. Yue, X. Li, S. Li, and Y.A. Zhang The effect of long-term streptozotocin-induced diabetes mellitus (STZ-DM) on cynomolgus (Macaca fascicularis) monkeys J. Med. Primatol. 38 2009 15 22
138. M. Yamada, B. Johannesson, I. Sagi, L.C. Burnett, D.H. Kort, R.W. Prosser, D. Paull, M.W. Nestor, M. Freeby, and E. Greenberg Human oocytes reprogram adult somatic nuclei of a type 1 diabetic to diploid pluripotent stem cells Nature 510 2014 533 536
139. C.J. Yeo, J.L. Cameron, T.A. Sohn, K.D. Lillemoe, H.A. Pitt, M.A. Talamini, R.H. Hruban, S.E. Ord, P.K. Sauter, J. Coleman, M.L. Zahurak, L.B. Grochow, and R.A. Abrams Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes discussion 257-260 Ann. Surg. 226 1997 248 257
140. Q. Zhou, J. Brown, A. Kanarek, J. Rajagopal, and D.A. Melton In vivo reprogramming of adult pancreatic exocrine cells to beta-cells Nature 455 2008 627 632
141. H. Zhu, L. Yu, Y. He, and B. Wang Nonhuman primate models of type 1 diabetes mellitus for islet transplantation J. Diabetes Res. 2014 2014 785948